Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65426 - 65450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	NEIL2	252969	upregulated	resveratrol results in increased expression of NEIL2 mRNA	8p23.1	A22289
Resveratrol	Investigational	NEK2	4751	downregulated	resveratrol results in decreased expression of NEK2 mRNA	1q32.3	A23857
Resveratrol	Investigational	NES	10763	downregulated	resveratrol results in decreased expression of NES mRNA	1q23.1	A23897
Resveratrol	Investigational	NFAT5	10725	downregulated	resveratrol results in decreased expression of NFAT5 mRNA	16q22.1	A23854
Resveratrol	Investigational	NFE2L1	4779	upregulated	resveratrol results in increased expression of NFE2L1 mRNA	17q21.3	A20916
Resveratrol	Investigational	NFE2L2	4780	downregulated	resveratrol results in decreased expression of NFE2L2 mRNA	2q31.2	A23854
Resveratrol	Investigational	NFE2L2	4780	upregulated	resveratrol results in increased expression of NFE2L2 mRNA	2q31.2	A23947
Resveratrol	Investigational	NFE2L3	9603	downregulated	resveratrol results in decreased expression of NFE2L3 mRNA	7p15.2	A20916
Resveratrol	Investigational	NFIX	4784	upregulated	resveratrol results in increased expression of NFIX mRNA	19p13.13	A22498
Resveratrol	Investigational	NFKB1	4790	upregulated	resveratrol results in increased expression of NFKB1 mRNA	4q24	A22435
Resveratrol	Investigational	NFKB2	4791	downregulated	resveratrol results in decreased expression of NFKB2 mRNA	10q24.32	A22498
Resveratrol	Investigational	NFKBIA	4792	upregulated	resveratrol results in increased expression of NFKBIA mRNA	14q13.2	A23969
Resveratrol	Investigational	NFKBIZ	64332	downregulated	resveratrol results in decreased expression of NFKBIZ mRNA	3q12.3	A23969
Resveratrol	Investigational	NGFR	4804	upregulated	resveratrol results in increased expression of NGFR mRNA	17q21.33	A23909
Resveratrol	Investigational	NINL	22981	downregulated	resveratrol results in decreased expression of NINL mRNA	20p11.21	A21103
Resveratrol	Investigational	NKX2-1	7080	upregulated	resveratrol results in increased expression of NKX2-1 mRNA	14q13.3	A23943
Resveratrol	Investigational	NKX3-1	4824	downregulated	resveratrol results in decreased expression of NKX3-1 mRNA	8p21.2	A21310 A23965 A23966
Resveratrol	Investigational	NLRP1	22861	upregulated	resveratrol results in increased expression of NLRP1 mRNA	17p13	A23845
Resveratrol	Investigational	NLRP3	114548	upregulated	resveratrol results in increased expression of NLRP3 mRNA	1q44	A23845
Resveratrol	Investigational	NMU	10874	upregulated	resveratrol results in increased expression of NMU mRNA	4q12	A23908
Resveratrol	Investigational	NOP56	10528	downregulated	resveratrol results in decreased expression of NOP56 mRNA	20p13	A22498
Resveratrol	Investigational	NOS2	4843	downregulated	resveratrol results in decreased expression of NOS2 mRNA	17q11.2	A21627 A23986
Resveratrol	Investigational	NOS3	4846	downregulated	resveratrol results in decreased expression of NOS3 mRNA	7q36.1	A23987 A23876
Resveratrol	Investigational	NOS3	4846	upregulated	[resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 mRNA	7q36.1	A23988
Resveratrol	Investigational	NOS3	4846	upregulated	resveratrol results in increased expression of and results in increased stability of NOS3 mRNA	7q36.1	A23989

Displaying entries 65426 - 65450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability